RINVOQ® Upadacitinib 15 mg Tablet 30 Tablets

Name: Janus Kinase (JAK) Inhibitor
Brand: RINVOQ®

RINVOQ ER, TAB 15MG (30/EA)

McKesson #

1198059

Manufacturer #

00074230630

Brand

RINVOQ®

Manufacturer

AbbVie Inc

Country of Origin

Unknown

Application

Janus Kinase (JAK) Inhibitor

Container Type

Bottle

Dosage Form

Tablet

Generic Drug Code

46822

Generic Drug Name

Upadacitinib

NDC Number

00074230630

Product Dating

McKesson Acceptable Dating: we will ship >= 90 days

Quantity

30 Tablets

Strength

15 mg

Type

Extended Release

UNSPSC Code

51386600

RINVOQ® (upadacitinib) is indicated for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to one or more TNF blockers
Active psoriatic arthritis when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated